Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Ceska a Slovenska Farmacie : Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti|June 9, 2011
Study on 99mTc-MAG3 and 99mTc-DMSA renal accumulation using in vitro cellular modelZbynĕk Nový, Jana Mandíková, Frantisek TrejtnarNuclear Medicine and Biology|December 21, 2002
Comparison of 99mTc-mercaptoacetyltriglycine and [131I]-o-iodohippurate elimination in perfused rat kidneyFrantisek Trejtnar, Milan Laznicek, Alice LaznickovaJournal of Labelled Compounds & Radiopharmaceuticals|December 15, 2016
In vitro evaluation of concentration, labeling effectiveness and stability for 131 I-labeled radioimmunoassay ligand using real-time detection technologyPavel Barta, Jiri Janousek, Katerina Zilkova, et al.Chirality|August 19, 2003
Stereoselective pharmacokinetics and metabolism of flobufen in guinea pigsFrantisek Trejtnar, Radim Král, Petr Pávek, et al.Drug Metabolism Reviews|June 10, 2016
Expression of organic cation transporter 1 (OCT1): unique patterns of indirect regulation by nuclear receptors and hepatospecific gene regulationLucie Hyrsova, Tomas Smutny, Frantisek Trejtnar, et al.Anticancer Research|February 4, 2019
Antiangiogenic Human Monoclonal Antibody Ramucirumab Radiolabelling: In Vitro Evaluation on VEGFR2-positive Cell LinesJiri Janousek, Pavel Barta, Zbynek Novy, et al.Nuclear Medicine and Biology|April 14, 2012
A comparison of in vitro methods for determining the membrane receptor expression in cell linesZbynek Novy, Pavel Barta, Jana Mandikova, et al.Pharmaceuticals (Basel, Switzerland)|May 27, 2023
Validation of Freshly Isolated Rat Renal Cells as a Tool for Preclinical Assessment of Radiolabeled Receptor-Specific Peptide Uptake in the KidneyPavel Barta, Petr Nachtigal, Jana Maixnerova, et al.Journal of Labelled Compounds & Radiopharmaceuticals|June 4, 2014
The effect of chelator type on in vitro receptor binding and stability in 177Lu-labeled cetuximab and panitumumabZbynek Novy, Alice Laznickova, Jana Mandikova, et al.Journal of Labelled Compounds & Radiopharmaceuticals|April 5, 2021
Preclinical evaluation of anti-VEGFR2 monoclonal antibody ramucirumab labelled with zirconium-89 for tumour imagingZbynek Novy, Jiri Janousek, Pavel Barta, et al.Pageof 3